Co-diagnostics completes fda eua submission for extraction-free saliva covid-19 test

Salt lake city, jan. 28, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed its submission to the u.s. food...
CODX Ratings Summary
CODX Quant Ranking